The pharmaceutical composition of the invention can be produced by a known method, such as the method described in the General Rules for Preparations of the Japanese Pharmacopoeia, 16th Edition. The pharmaceutical composition of the invention can be appropriately administered to a patient according to...
Remington, “Pharmaceutical Manufacturing,” Part 5, The Science and Practice of Pharmacy, 21st Edition, 5 pages (2005). Saleh, M.A. et al, “Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease,” The Journal of Pharm...
Rafferty et al., “International Standards for hepatocyte growth factor/scatter factor; initial assessment of candidate materials and their evaluation by multicentre collaborative study”, Journal of Immunological Methods, vol. 258, p. 1-11, 2001. The Japanese Pharmacopoeia Sixteenth Edition, p. 113...
However, Absinthii tinctura is not mentioned in the latest (10th) edition of the European Pharmacopoeia [69]. According to ESCOP (European Scientific Cooperative on Phytotherapy), Absinthii herba may be used in digestive disorders. Anorexia is also mentioned among the indications. ESCOP recommends...
However, Absinthii tinctura is not mentioned in the latest (10th) edition of the European Pharmacopoeia [69]. According to ESCOP (European Scientific Cooperative on Phytotherapy), Absinthii herba may be used in digestive disorders. Anorexia is also mentioned among the indications. ESCOP recommends...
However, Absinthii tinctura is not mentioned in the latest (10th) edition of the European Pharmacopoeia [69]. According to ESCOP (European Scientific Cooperative on Phytotherapy), Absinthii herba may be used in digestive disorders. Anorexia is also mentioned among the indications. ESCOP recommends...